1. Home
  2. AGRO vs NRIX Comparison

AGRO vs NRIX Comparison

Compare AGRO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGRO
  • NRIX
  • Stock Information
  • Founded
  • AGRO 2002
  • NRIX 2009
  • Country
  • AGRO Luxembourg
  • NRIX United States
  • Employees
  • AGRO N/A
  • NRIX N/A
  • Industry
  • AGRO Farming/Seeds/Milling
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGRO Consumer Staples
  • NRIX Health Care
  • Exchange
  • AGRO Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • AGRO 1.1B
  • NRIX 908.0M
  • IPO Year
  • AGRO 2011
  • NRIX 2020
  • Fundamental
  • Price
  • AGRO $9.37
  • NRIX $12.73
  • Analyst Decision
  • AGRO Hold
  • NRIX Strong Buy
  • Analyst Count
  • AGRO 4
  • NRIX 16
  • Target Price
  • AGRO $11.60
  • NRIX $30.44
  • AVG Volume (30 Days)
  • AGRO 375.1K
  • NRIX 747.9K
  • Earning Date
  • AGRO 08-11-2025
  • NRIX 07-10-2025
  • Dividend Yield
  • AGRO 3.65%
  • NRIX N/A
  • EPS Growth
  • AGRO N/A
  • NRIX N/A
  • EPS
  • AGRO 0.62
  • NRIX N/A
  • Revenue
  • AGRO $1,582,638,000.00
  • NRIX $56,417,000.00
  • Revenue This Year
  • AGRO $1.59
  • NRIX $16.69
  • Revenue Next Year
  • AGRO $0.84
  • NRIX N/A
  • P/E Ratio
  • AGRO $15.14
  • NRIX N/A
  • Revenue Growth
  • AGRO 20.41
  • NRIX N/A
  • 52 Week Low
  • AGRO $8.45
  • NRIX $8.18
  • 52 Week High
  • AGRO $12.08
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • AGRO 52.56
  • NRIX 62.83
  • Support Level
  • AGRO $9.04
  • NRIX $11.34
  • Resistance Level
  • AGRO $9.29
  • NRIX $12.90
  • Average True Range (ATR)
  • AGRO 0.19
  • NRIX 0.66
  • MACD
  • AGRO 0.01
  • NRIX 0.02
  • Stochastic Oscillator
  • AGRO 61.67
  • NRIX 90.17

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The company operates through three segments namely Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment consists of planting, harvesting, and sale of grains, oilseeds and fibers, rice, and production and sale of dairy products; the Sugar, Ethanol, and Energy segment consists of cultivating sugar cane which is processed in owned sugar mills, transformed into ethanol; and the Land Transformation segment comprises identification and acquisition of underdeveloped and undermanaged farmland.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: